Arch Biopartners ACHFF Stock
Arch Biopartners Price Chart
Arch Biopartners ACHFF Financial and Trading Overview
| Arch Biopartners stock price | 1.72 USD |
| Previous Close | 1.46 USD |
| Open | 1.48 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.48 - 1.51 USD |
| 52 Week Range | 1.35 - 2.9 USD |
| Volume | 67.4K USD |
| Avg. Volume | 28.25K USD |
| Market Cap | 94.52M USD |
| Beta (5Y Monthly) | 1.101056 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.75 USD |
ACHFF Valuation Measures
| Enterprise Value | 95.36M USD |
| Trailing P/E | N/A |
| Forward P/E | -21.571428 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 39.8426 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 40.193 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Arch Biopartners Stock Price History
| Beta (5Y Monthly) | 1.101056 |
| 52-Week Change | -31.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.9 USD |
| 52 Week Low | 1.35 USD |
| 50-Day Moving Average | 1.49 USD |
| 200-Day Moving Average | 1.93 USD |
ACHFF Share Statistics
| Avg. Volume (3 month) | 28.25K USD |
| Avg. Daily Volume (10-Days) | 20.8K USD |
| Shares Outstanding | 62.6M |
| Float | 48.81M |
| Short Ratio | N/A |
| % Held by Insiders | 19.15% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -162.93% |
| Operating Margin (ttm) | -146.16% |
| Gross Margin | -40.038% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.11% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.37M USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | 125.29% |
| Gross Profit (ttm) | -502879 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3865629 USD |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 708.49K USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 5.92M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.542 |
| Book Value Per Share (mrq) | -0.087 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1660971 USD |
| Levered Free Cash Flow (ttm) | -467076 USD |
Profile of Arch Biopartners
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 27 Street Clair Avenue East |
| ZIP | M4T 2M5 |
| Phone | 647-428-7031 |
| Website | https://www.archbiopartners.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Arch Biopartners Inc., a biotechnology company, engages in the development of technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds. In addition, it develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is based in Toronto, Canada.
Q&A For Arch Biopartners Stock
What is a current ACHFF stock price?
Arch Biopartners ACHFF stock price today per share is 1.72 USD.
How to purchase Arch Biopartners stock?
You can buy ACHFF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arch Biopartners?
The stock symbol or ticker of Arch Biopartners is ACHFF.
Which industry does the Arch Biopartners company belong to?
The Arch Biopartners industry is Biotechnology.
How many shares does Arch Biopartners have in circulation?
The max supply of Arch Biopartners shares is 63.17M.
What is Arch Biopartners Price to Earnings Ratio (PE Ratio)?
Arch Biopartners PE Ratio is now.
What was Arch Biopartners earnings per share over the trailing 12 months (TTM)?
Arch Biopartners EPS is -0.02 USD over the trailing 12 months.
Which sector does the Arch Biopartners company belong to?
The Arch Biopartners sector is Healthcare.